IMTX
Immatics N.V.
Price Chart
No historical data available
Latest Quote
$9.59
+0.23 (+2.46%)
Current Price
| Previous Close | $9.36 |
| Open | $9.68 |
| Day High | $9.88 |
| Day Low | $9.35 |
| Volume | 561,631 |
Stock Information
Note: Financial values converted from EUR to USD
| Shares Outstanding | 152.23M |
| Total Debt | $16.92M |
| Cash Equivalents | $455.79M |
| Revenue | $48.32M |
| Net Income | $-239.34M |
| Sector | Healthcare |
| Industry | Biotechnology |
| Market Cap | $1.44B |
| EPS (TTM) | $-1.86 |
| Exchange | NCM |
Recent Price History
No history data available. Data will be fetched automatically.
About Immatics N.V.
Immatics N.V., a clinical-stage biopharmaceutical company, focuses on the research and development of potential T cell redirecting immunotherapies for the treatment of cancer in the United States. The company is developing targeted immunotherapies with a focus on treating solid tumors through two distinct treatment modalities, such as adoptive cell therapies (ACT) and antibody-like TCR Bispecifics. Its products pipeline includes Anzu-cel (IMA203), a one-time infusion PRAME cell therapy, which is in Phase 2 trial; IMA203CD8, a cell therapy product that is in Phase 1 clinical trial; IMA204 that targets tumor stroma, which is in Phase 1 clinical trial; and Anzu-cel in combination with Moderna's PRAME cell therapy enhancer (mRNA-4203), which is in Phase 1 clinical trial. The company also develops TCR Bispecifics products, including IMA401 and IMA402, which is in Phase 1a clinical trial. The company has a strategic collaboration agreement with MD Anderson Cancer Center to develop multiple T cell and TCR-based adoptive cellular therapies; Celgene Corporation to develop novel adoptive cell therapies targeting multiple cancers; and Genmab A/S to develop T cell engaging bispecific immunotherapies targeting multiple cancer indications. Immatics N.V. is headquartered in TÃŧbingen, Germany.
đ° Latest News
No news articles available at the moment. Check back later for updates on IMTX.
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Total Revenue | $56,306,580 | $181,795,381 | $62,992,301 | $201,622,726 |
| Operating Revenue | $56,306,580 | $181,795,381 | $62,992,301 | $201,622,726 |
| Expenses | ||||
| Interest Expense | $1,103,593 | $1,033,598 | $969,435 | $1,210,919 |
| Total Expenses | $268,644,425 | $226,843,212 | $181,663,557 | $166,678,722 |
| Other Income Expense | $-38,092,627 | $41,817,546 | $-9,662,856 | $12,417,172 |
| Net Non Operating Interest Income Expense | $18,937,238 | $28,132,291 | $15,181,988 | $1,677,555 |
| Interest Expense Non Operating | $1,103,593 | $1,033,598 | $969,435 | $1,210,919 |
| Operating Expense | $268,644,425 | $226,843,212 | $181,663,557 | $166,678,722 |
| Other Operating Expenses | $-5,522,632 | $-90,994 | $-1,328,745 | $-30,331 |
| General And Administrative Expense | $59,710,686 | $54,186,888 | $44,561,363 | $42,141,857 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $-229,172,890 | $17,753,150 | $-110,416,473 | $32,318,012 |
| Net Interest Income | $18,937,238 | $28,132,291 | $15,181,988 | $1,677,555 |
| Interest Income | $20,040,831 | $29,165,889 | $16,151,423 | $2,888,474 |
| Normalized Income | $-191,462,079 | $-12,059,434 | $-100,987,233 | $24,134,719 |
| Net Income From Continuing And Discontinued Operation | $-229,172,890 | $17,753,150 | $-110,416,473 | $32,318,012 |
| Total Operating Income As Reported | $-212,337,845 | $-45,047,830 | $-118,671,256 | $34,944,004 |
| Net Income Common Stockholders | $-229,172,890 | $17,753,150 | $-110,416,473 | $32,318,012 |
| Net Income | $-229,172,890 | $17,753,150 | $-110,416,473 | $32,318,012 |
| Net Income Including Noncontrolling Interests | $-229,172,890 | $17,753,150 | $-110,416,473 | $32,318,012 |
| Net Income Continuous Operations | $-229,172,890 | $17,753,150 | $-110,416,473 | $32,318,012 |
| Pretax Income | $-231,493,235 | $24,902,007 | $-113,152,124 | $49,038,731 |
| Interest Income Non Operating | $20,040,831 | $29,165,889 | $16,151,423 | $2,888,474 |
| Operating Income | $-212,337,845 | $-45,047,830 | $-118,671,256 | $34,944,004 |
| Special Income Charges | - | - | - | $0 |
| Per Share | ||||
| Diluted EPS | $-1.88 | $0.16 | $-1.38 | $0.64 |
| Basic EPS | $-1.88 | $0.16 | $-1.38 | $0.65 |
| Other | ||||
| Tax Effect Of Unusual Items | $-381,817 | $12,004,962 | $-233,616 | $4,233,879 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $-177,831,312 | $-1,620,392 | $-94,080,728 | $45,960,103 |
| Total Unusual Items | $-38,092,627 | $41,817,546 | $-9,662,856 | $12,417,172 |
| Total Unusual Items Excluding Goodwill | $-38,092,627 | $41,817,546 | $-9,662,856 | $12,417,172 |
| Reconciled Depreciation | $14,465,702 | $14,261,549 | $8,439,104 | $8,127,625 |
| EBITDA (Bullshit earnings) | $-215,923,940 | $40,197,154 | $-103,743,584 | $58,377,275 |
| EBIT | $-230,389,642 | $25,935,604 | $-112,182,688 | $50,249,650 |
| Diluted Average Shares | $142,730,325 | $124,585,978 | $93,964,865 | $79,569,848 |
| Basic Average Shares | $142,730,325 | $123,360,860 | $93,964,865 | $78,148,957 |
| Diluted NI Availto Com Stockholders | $-229,172,890 | $17,753,150 | $-110,416,473 | $32,318,012 |
| Tax Provision | $-2,320,345 | $7,148,857 | $-2,735,651 | $16,720,719 |
| Gain On Sale Of Security | $-38,092,627 | $41,817,546 | $-9,662,856 | $12,417,172 |
| Research And Development | $214,456,371 | $172,747,318 | $138,430,939 | $124,567,196 |
| Selling General And Administration | $59,710,686 | $54,186,888 | $44,561,363 | $42,141,857 |
| Other Gand A | $29,045,730 | $26,789,547 | $44,561,363 | $42,141,857 |
| Salaries And Wages | $30,664,956 | $27,397,340 | $25,408,306 | $24,408,540 |
| Minority Interests | - | - | - | $0 |
| Restructuring And Mergern Acquisition | - | - | - | $0 |
Fetched: 2026-08-25
Balance Sheet (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $562,898,976 | $668,703,923 | $252,094,028 | $235,325,479 |
| Total Assets | $656,016,102 | $812,116,196 | $594,919,508 | $475,758,285 |
| Total Non Current Assets | $68,045,964 | $77,684,321 | $70,689,454 | $35,774,615 |
| Other Non Current Assets | $897,107 | $1,069,762 | $703,453 | $2,968,969 |
| Non Current Prepaid Assets | $1,261,083 | $388,474 | $1,649,557 | $2,223,518 |
| Goodwill And Other Intangible Assets | $1,845,544 | $1,900,373 | $1,776,715 | $1,903,873 |
| Other Intangible Assets | $1,845,544 | $1,900,373 | $1,776,715 | $1,903,873 |
| Current Assets | $587,970,138 | $734,431,875 | $524,230,054 | $439,983,670 |
| Other Current Assets | $17,347,177 | $7,361,176 | $8,304,946 | $16,143,257 |
| Prepaid Assets | $15,072,329 | $14,055,063 | $12,388,008 | $12,190,854 |
| Receivables | $8,027,298 | $7,868,642 | $6,692,721 | $1,296,080 |
| Taxes Receivable | $912,273 | $1,035,931 | $1,917,872 | $1,202,753 |
| Accounts Receivable | $7,115,026 | $6,832,711 | $4,774,848 | $1,296,080 |
| Cash Cash Equivalents And Short Term Investments | $547,523,335 | $705,146,994 | $496,844,380 | $422,544,333 |
| Cash And Cash Equivalents | $403,544,099 | $276,187,589 | $254,867,010 | $173,260,617 |
| Hedging Assets Current | - | - | - | - |
| Other Receivables | - | - | - | - |
| Debt | ||||
| Total Debt | $18,239,617 | $18,902,240 | $17,967,802 | $16,987,868 |
| Long Term Debt And Capital Lease Obligation | $15,023,332 | $15,576,295 | $14,930,005 | $14,469,202 |
| Current Debt And Capital Lease Obligation | $3,216,286 | $3,325,945 | $3,037,797 | $2,518,665 |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $91,271,582 | $141,511,900 | $341,048,765 | $238,528,933 |
| Total Non Current Liabilities Net Minority Interest | $41,094,261 | $62,199,020 | $158,416,940 | $114,343,211 |
| Non Current Deferred Liabilities | $26,070,929 | $46,622,725 | $143,482,269 | $99,825,012 |
| Non Current Deferred Taxes Liabilities | $4,441,204 | $6,770,882 | $8,709,753 | $11,445,404 |
| Current Liabilities | $50,177,322 | $79,312,880 | $182,631,825 | $124,185,722 |
| Other Current Liabilities | $1,808,213 | $3,717,919 | $22,405,506 | $30,657,956 |
| Current Deferred Liabilities | $18,450,770 | $41,889,874 | $117,126,692 | $75,778,115 |
| Payables And Accrued Expenses | $24,710,686 | $28,537,098 | $38,572,095 | $15,230,985 |
| Payables | $3,138,124 | $16,193,421 | $18,110,126 | $15,230,985 |
| Total Tax Payable | $2,741,484 | $4,396,874 | $9,167,056 | $9,010,733 |
| Income Tax Payable | $37,331 | $2,054,363 | $5,013,999 | $5,013,999 |
| Accounts Payable | $396,640 | $11,796,547 | $8,943,071 | $15,230,985 |
| Other Non Current Liabilities | - | - | $4,666 | $48,997 |
| Equity | ||||
| Common Stock Equity | $564,744,520 | $670,604,296 | $253,870,743 | $237,229,353 |
| Total Equity Gross Minority Interest | $564,744,520 | $670,604,296 | $253,870,743 | $237,229,353 |
| Stockholders Equity | $564,744,520 | $670,604,296 | $253,870,743 | $237,229,353 |
| Gains Losses Not Affecting Retained Earnings | $-10,023,332 | $1,202,753 | $-1,908,539 | $-1,727,718 |
| Other Equity Adjustments | $-10,023,332 | $1,202,753 | $-1,908,539 | $-1,727,718 |
| Retained Earnings | $-916,924,876 | $-687,751,987 | $-705,505,137 | $-595,088,664 |
| Other | ||||
| Ordinary Shares Number | $156,406,244 | $141,799,078 | $98,760,837 | $89,443,186 |
| Share Issued | $156,406,244 | $141,799,078 | $98,760,837 | $89,443,186 |
| Tangible Book Value | $562,898,976 | $668,703,923 | $252,094,028 | $235,325,479 |
| Invested Capital | $564,744,520 | $670,604,296 | $253,870,743 | $237,229,353 |
| Working Capital | $537,792,817 | $655,118,995 | $341,598,229 | $315,797,948 |
| Capital Lease Obligations | $18,239,617 | $18,902,240 | $17,967,802 | $16,987,868 |
| Total Capitalization | $564,744,520 | $670,604,296 | $253,870,743 | $237,229,353 |
| Additional Paid In Capital | $1,490,128,332 | $1,355,734,958 | $960,296,318 | $833,150,961 |
| Capital Stock | $1,564,396 | $1,418,572 | $988,101 | $894,774 |
| Common Stock | $1,564,396 | $1,418,572 | $988,101 | $894,774 |
| Non Current Deferred Revenue | $21,629,725 | $39,851,843 | $134,772,516 | $88,379,608 |
| Long Term Capital Lease Obligation | $15,023,332 | $15,576,295 | $14,930,005 | $14,469,202 |
| Current Deferred Revenue | $18,450,770 | $41,889,874 | $117,126,692 | $75,778,115 |
| Current Capital Lease Obligation | $3,216,286 | $3,325,945 | $3,037,797 | $2,518,665 |
| Pensionand Other Post Retirement Benefit Plans Current | $1,991,367 | $1,842,044 | $1,489,734 | $940,271 |
| Current Accrued Expenses | $21,572,562 | $12,343,677 | $20,461,969 | $11,328,745 |
| Net PPE | $64,042,231 | $74,325,712 | $66,559,730 | $30,901,773 |
| Accumulated Depreciation | $-34,721,185 | $-37,404,340 | $-26,674,055 | $-23,894,074 |
| Gross PPE | $98,763,416 | $111,730,052 | $93,233,785 | $54,795,847 |
| Leases | $33,555,763 | $36,650,723 | $29,646,524 | $4,475,035 |
| Other Properties | $40,142,324 | $44,888,008 | $35,708,120 | $41,374,242 |
| Machinery Furniture Equipment | $10,380,308 | $14,846,010 | $12,889,641 | $8,946,570 |
| Buildings And Improvements | $14,685,021 | $15,345,310 | $14,989,501 | $14,476,202 |
| Properties | $0 | $0 | $0 | $0 |
| Other Short Term Investments | $143,979,235 | $428,959,405 | $241,977,369 | $249,283,716 |
| Current Provisions | - | - | - | - |
Fetched: 2026-08-25
Cash Flow Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $-213,988,569 | $-203,581,429 | $-14,849,510 | $109,561,363 |
| Operating Activities | ||||
| Operating Cash Flow | $-206,049,931 | $-184,356,044 | $21,264,582 | $116,811,713 |
| Cash Flow From Continuing Operating Activities | $-206,049,931 | $-184,356,044 | $21,264,582 | $116,811,713 |
| Operating Gains Losses | $38,674,755 | $-41,961,036 | $10,254,316 | $-9,323,378 |
| Investing Activities | ||||
| Capital Expenditure | $-7,938,637 | $-19,225,385 | $-36,114,093 | $-7,250,350 |
| Investing Cash Flow | $238,902,241 | $-177,772,983 | $-36,616,892 | $-244,739,852 |
| Cash Flow From Continuing Investing Activities | $238,902,241 | $-177,772,983 | $-36,616,892 | $-244,739,852 |
| Financing Activities | ||||
| Issuance Of Capital Stock | $125,186,655 | $400,151,659 | $105,464,303 | $156,887,542 |
| Financing Cash Flow | $113,570,929 | $372,939,806 | $98,595,427 | $144,318,713 |
| Cash Flow From Continuing Financing Activities | $113,570,929 | $372,939,806 | $98,595,427 | $144,318,713 |
| Net Other Financing Charges | $-8,163,789 | $-24,864,676 | $-2,378,675 | $-9,252,217 |
| Net Common Stock Issuance | $125,186,655 | $400,151,659 | $105,464,303 | $156,887,542 |
| Common Stock Issuance | $125,186,655 | $400,151,659 | $105,464,303 | $156,887,542 |
| Other | ||||
| Repayment Of Debt | $-3,451,937 | $-2,347,177 | $-4,490,201 | $-3,316,612 |
| End Cash Position | $403,544,099 | $276,187,589 | $254,867,010 | $173,260,617 |
| Beginning Cash Position | $276,187,589 | $254,867,010 | $173,260,617 | $155,149,324 |
| Effect Of Exchange Rate Changes | $-19,066,729 | $10,509,799 | $-1,636,724 | $1,720,719 |
| Changes In Cash | $146,423,239 | $10,810,779 | $83,243,118 | $16,390,574 |
| Net Issuance Payments Of Debt | $-3,451,937 | $-2,347,177 | $-4,490,201 | $-3,316,612 |
| Net Long Term Debt Issuance | $-3,451,937 | $-2,347,177 | $-4,490,201 | $-3,316,612 |
| Long Term Debt Payments | $-3,451,937 | $-2,347,177 | $-4,490,201 | $-3,316,612 |
| Net Investment Purchase And Sale | $246,840,879 | $-158,549,931 | $-677,788 | $-237,550,165 |
| Sale Of Investment | $641,459,406 | $366,822,214 | $483,835,747 | $14,809,846 |
| Purchase Of Investment | $-394,618,527 | $-525,372,145 | $-484,513,535 | $-252,360,011 |
| Net Intangibles Purchase And Sale | $-288,147 | $-242,650 | $-184,321 | $-556,463 |
| Purchase Of Intangibles | $-288,147 | $-242,650 | $-184,321 | $-556,463 |
| Net PPE Purchase And Sale | $-7,650,490 | $-18,980,401 | $-35,754,783 | $-6,633,224 |
| Sale Of PPE | $0 | $2,333 | $174,988 | $60,663 |
| Purchase Of PPE | $-7,650,490 | $-18,982,735 | $-35,929,772 | $-6,693,887 |
| Taxes Refund Paid | $-5,167,989 | $-15,279,981 | $-3,453,103 | $-261,316 |
| Interest Received Cfo | $31,284,415 | $18,204,620 | $11,860,709 | $1,923,705 |
| Interest Paid Cfo | $-1,103,593 | $-1,033,598 | $-338,311 | $-810,779 |
| Change In Working Capital | $-51,289,081 | $-175,898,274 | $98,681,755 | $43,464,769 |
| Change In Other Working Capital | $-43,881,241 | $-174,688,522 | $100,325,479 | $53,148,624 |
| Change In Other Current Assets | $-7,125,525 | $848,110 | $1,835,044 | $-9,183,388 |
| Change In Receivables | $-282,315 | $-2,057,863 | $-3,478,768 | $-500,467 |
| Changes In Account Receivables | $-282,315 | $-2,057,863 | $-3,478,768 | $-500,467 |
| Other Non Cash Items | $-18,937,238 | $-28,132,291 | $-15,181,988 | $-1,677,555 |
| Stock Based Compensation | $17,516,332 | $20,580,961 | $24,154,223 | $26,329,911 |
| Deferred Tax | $-2,320,345 | $7,148,857 | $-2,735,651 | $16,720,719 |
| Deferred Income Tax | $-2,320,345 | $7,148,857 | $-2,735,651 | $16,720,719 |
| Depreciation Amortization Depletion | $14,465,702 | $14,261,549 | $8,439,104 | $8,127,625 |
| Depreciation And Amortization | $14,465,702 | $14,261,549 | $8,439,104 | $8,127,625 |
| Gain Loss On Investment Securities | $-2,018,199 | $-20,139,991 | $2,425,338 | $-12,768,316 |
| Net Foreign Currency Exchange Gain Loss | $39,818,012 | $-21,822,212 | $8,003,966 | $3,444,937 |
| Gain Loss On Sale Of PPE | $874,942 | $1,167 | $-174,988 | $0 |
| Net Income From Continuing Operations | $-229,172,890 | $17,753,150 | $-110,416,473 | $32,318,012 |
| Change In Payables And Accrued Expense | - | - | - | - |
| Change In Payable | - | - | - | - |
| Change In Account Payable | - | - | - | - |
Fetched: 2026-08-25